Remaxol Hepatoprotective Therapy of Patients with Tuberculosis and HIV Infection in Day Unit of Tuberculosis Dispensary
To improve the treatment of hepatotoxic responses to antituberculosis polychemotherapy, the impact of remaxol on the biochemical indices and parameters of the antioxidant system in patients with tuberculosis and HIV infection was estimated. The use of remaxol having cytoprotective, anticholestatic,...
Saved in:
Main Authors: | E. V. Shevyreva, A. K. Ivanov, D. S. Sukhanov, A. A. Murzina |
---|---|
Format: | Article |
Language: | Russian |
Published: |
LLC "Publishing House OKI"
2020-05-01
|
Series: | Антибиотики и Химиотерапия |
Subjects: | |
Online Access: | https://www.antibiotics-chemotherapy.ru/jour/article/view/446 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Investigation of Remaxol Efficacy in Complex Therapy of Experimental Generalized Tuberculosis on Mice
by: D. S. Sukhanov, et al.
Published: (2020-05-01) -
Application of Hepatoprotector Remaxol in the Treatment of Patients Co-Infected with Tuberculosis, HIV, and Chronic Hepatitis C
by: YU. G. Pritulina, et al.
Published: (2020-05-01) -
Efficiency of Remaxol Use in Supporting Treatment of Advanced Tuberculosis
by: V. M. Kolomiets, et al.
Published: (2020-05-01) -
Some Peculiarities of Modern Comorbid Tuberculosis Therapy
by: V. M. Kolomiets, et al.
Published: (2023-02-01) -
Comparative Study of Hepatoprotective Action of Remaxol, Reamberin and Ademethionine in Liver Injury Induced by Antituberculosis Drugs (Experimental Study)
by: D. S. Sukhanov, et al.
Published: (2020-05-01)